H+E Pharma GmbH and its subsidiary S-Tec GmbH have been sold to BW Water GmbH, enhancing the latter's capabilities in the ultrapure water market.
Target Information
H+E Pharma GmbH, along with its subsidiary S-Tec GmbH, has been strategically advised by Saxenhammer exclusively during its sale to BW Water GmbH. This transaction also included the transfer of property to the buyer. H+E Pharma and S-Tec specialize in the production and distribution of ultrapure water systems primarily for the pharmaceutical and semiconductor industries. S-Tec focuses on plant engineering, whereas H+E Pharma is responsible for the maintenance of these systems. Both companies are based in Silicon Saxony, in Klipphausen, close to Dresden.
BW Water, headquartered in Stuttgart, is part of the BW Group, which is based in Singapore. The company is internationally recognized as a market leader in providing water and wastewater solutions for both industrial and municipal markets. BW Water handles the planning, construction, and service of facilities related to water and wastewater treatment.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The water treatment industry in Germany is experiencing significant growth as a result of increasing regulations and the ever-growing demand for clean water. With industrial applications ranging from pharmaceuticals
Similar Deals
Montrose Environmental Group, Inc. → Montrose Environmental Group Denmark
2026
BW Water GmbH
invested in
H+E Pharma GmbH and S-Tec GmbH
in 2023
in a Merger deal